LONOPIN PEN 300MG

About

LONOPIN PEN 300MG contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) with potent antithrombotic properties. It primarily exerts its anticoagulant effect by potentiating the activity of antithrombin III, leading to the selective inactivation of Factor Xa in the coagulation cascade. This targeted action effectively prevents the formation and growth of blood clots without significantly affecting other clotting factors or platelet function at therapeutic doses. Enoxaparin has a more predictable pharmacokinetic profile, a longer half-life, and a lower incidence of heparin-induced thrombocytopenia compared to unfractionated heparin.

Administered via subcutaneous injection, it is a widely used and effective agent for both the prophylaxis and treatment of various thromboembolic disorders. Its consistent anticoagulant response often allows for fixed dosing without the need for routine laboratory monitoring, making it a convenient option for both hospital and outpatient settings.

Uses

• Treatment of deep vein thrombosis (DVT).
• Treatment of pulmonary embolism (PE).
• Prevention of DVT in surgical patients.
• Prevention of DVT in acutely ill medical patients.

Directions For Use

Administer subcutaneously as directed by a healthcare professional. Do not inject intramuscularly.

Benefits

• Effective in preventing and treating blood clots.
• More predictable anticoagulant effect than unfractionated heparin.
• Lower risk of heparin-induced thrombocytopenia.
• Convenient subcutaneous administration.
• Does not require routine laboratory monitoring in most cases.
• Reduces risk of recurrent thromboembolic events.

Side Effects

• Bleeding (major and minor)
• Injection site hematoma
• Thrombocytopenia
• Anemia
• Elevated liver enzymes
• Hypersensitivity reactions
• Osteoporosis (long-term use)
• Spinal/epidural hematoma (with neuraxial anesthesia)
• Skin necrosis
• Headache
• Nausea
• Fever

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it may increase the risk of bleeding.
• Pregnancy - Generally considered safe for use in pregnancy when indicated, but use with caution and under strict medical supervision.
• Breastfeeding - Compatible with breastfeeding; minimal amounts are excreted into breast milk and are poorly absorbed orally by the infant.
• Liver - Use with caution in severe liver impairment due to increased bleeding risk; monitor closely.
• Kidney - Dose adjustment is required in patients with severe renal impairment (CrCl < 30 mL/min) due to reduced clearance.
• Lung - No direct lung effects, but used to treat pulmonary embolism; monitor for signs of bleeding.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.